Abstract
The pharmacological therapy for genital herpes simplex virus (HSV) infection remains dominated by aciclovir, although a number of related compounds are currently under investigation. Recommended treatment for initial genital HSV infection is oral aciclovir 200mg 5 times daily for 5 days, with intravenous therapy reserved for complicated episodes. Although topical aciclovir may be of benefit, no improvement in the systemic symptoms is provided by this formulation. No preparation prevents the onset of recurrent episodes. The management of recurrent episodes is more controversial, with studies of episodic treatment with both topical and oral aciclovir yielding mixed and at times conflicting results. Episodic treatment with oral aciclovir initiated early by the patient appears to have the most favourable results, and if initiated at the onset of prodromal symptoms may abort the episode in some patients. In patients with frequent recurrences, suppressive therapy with oral aciclovir should be considered. A starting dose of 200mg 4 times daily appears to be the most effective, although 400mg twice daily may suffice. The total daily dose should be reduced as far as possible, and treatment should be interrupted on a yearly basis to dete...Continue Reading
Citations
Apr 1, 1999·Biotechnology and Bioengineering·R O'KeeffeN K Slater
Apr 1, 1996·Molecular Biotechnology·S Freeman, J M Gardiner
May 1, 1997·Journal of Nurse-midwifery·V A Roe, A Gudi
Jul 1, 1997·Antiviral Research·R Orozco-TopeteE J Rozhon
May 22, 2003·Dermatologic Clinics·Suneel Chilukuri, Ted Rosen
Apr 23, 2003·Clinics in Dermatology·Ronni WolfHagit Matz
Jan 1, 1997·Clinics in Dermatology·C White, A G Wardropper
Mar 10, 2011·Chemistry : a European Journal·Hai-Ming GuoGui-Rong Qu
May 19, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·S RassaiSa Abtahian
Apr 1, 1997·Dermatologic Clinics·L L McDonaldD M Buntin
Apr 11, 2017·Dermatologic Therapy·Ayman Abdelmaksoud
Mar 21, 2001·The Journal of General Virology·A M HarandiK Eriksson
Jun 19, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R M MayA R McLean
May 4, 2010·The Journal of Organic Chemistry·Hai-Ming GuoGui-Rong Qu